3D Bioprinting Market: Trends, Opportunities and Competitive Analysis 2023-2028

The future of the 3D bioprinting market looks promising with opportunities in the pharmaceutical & biotechnology and research organizations & academic institutes. The global 3D bioprinting market is expected to reach an estimated $5.0 billion by 2028 with a CAGR of 18.4% from 2023 to 2028. The major drivers for this market are growing demand for organ transplantation, rise in public and private funding to support research activities, and increasing usage of 3D bioprinting in cosmetic surgeries and drug discovery process.

3D Bioprinting Market by Segment

The study includes trends and forecast for the global 3D bioprinting market by technology, product, material, application, end use industry, and region, as follows:

3D Bioprinting Market by Technology [Value ($B) Shipment Analysis from 2017 to 2028]:

• Magnetic 3D Bioprinting
• Laser-assisted Bioprinting
• Inkjet 3D Bioprinting
• Microextrusion 3D Bioprinting
• Methyl Mercaptan Sensors
• Others

3D Bioprinting Market by Product [Value ($B) Shipment Analysis from 2017 to 2028]:

• 3D Bioprinters
• Biomaterials
• Scaffolds

3D Bioprinting Market by Material [Value ($B) Shipment Analysis from 2017 to 2028]:

• Living Cells
• Extracellular Matrices
• Hydrogels
• Others

3D Bioprinting Market by Application [Value ($B) Shipment Analysis from 2017 to 2028]:

• Clinical Applications
• Skin
• Bones
• Blood Vessels
• Research Applications
• Drug and Medical Research
• Regenerative Medicine
• 3D Cell Culture

3D Bioprinting Market by End Use Industry [Value ($B) Shipment Analysis from 2017 to 2028]:

• Pharmaceutical & Biotechnology Companies
• Research Organizations & Academic Institutes
• Others

3D Bioprinting Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of 3D Bioprinting Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, 3D bioprinting companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the 3D bioprinting companies profiled in this report include-

• Organovo Holdings
• Envisiontec
• Nano 3D Biosciences
• Cyfuse Biomedical
• Regenhu

3D Bioprinting Market Insights

The analyst forecasts that 3D bioprinters will remain the largest product segment over the forecast period due to the increasing number of clinical trials and drug testing process, which will help in significantly reducing animal testing.

Research organizations & academic institutes are expected to remain the largest end use industry segment due to the expanding research into portable 3D bioprinting technology that can be used to conveniently generate skin tissues and reduce scars in trauma care.

North America will remain the largest region due to growing prevalence of chronic diseases, sophisticated healthcare infrastructure along with high disposable income levels in the region, and extensive research activities.

Features of the 3D Bioprinting Market

• Market Size Estimates: 3D bioprinting market size estimation in terms of value ($B)
• Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
• Segmentation Analysis: 3D bioprinting market size by various segments, such as technology, product, material, application, end use industry, and region
• Regional Analysis: 3D bioprinting market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
• Growth Opportunities: Analysis on growth opportunities in different technology, products, materials, applications, end use industries, and regions for the 3D bioprinting market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape for the 3D bioprinting market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQS

Q1. What is the 3D bioprinting market size?
Answer: The global 3D bioprinting market is expected to reach an estimated $5.0 billion by 2028.

Q2. What is the growth forecast for 3D bioprinting market?
Answer: The global 3D bioprinting market is expected to grow with a CAGR of 18.4% from 2023 to 2028.

Q3. What are the major drivers influencing the growth of the 3D bioprinting market?
Answer: The major drivers for this market are growing demand for organ transplantation, rise in public and private funding to support research activities, and increasing usage of 3D bioprinting in cosmetic surgeries and drug discovery process.

Q4. What are the major segments for 3D bioprinting market?
Answer: The future of the 3D bioprinting market looks promising with opportunities in pharmaceutical & biotechnology and research organizations & academic institutes.

Q5. Who are the key 3D bioprinting companies?
Answer: Some of the key 3D bioprinting companies are as follows:

• Organovo Holdings
• Envisiontec
• Nano 3D Biosciences
• Cyfuse Biomedical
• Regenhu

Q6. Which 3D bioprinting segment will be the largest in the future?
Answer: The analyst forecasts that 3D bioprinters will remain the largest product segment over the forecast period due to the increasing number of clinical trials and drug testing process, which will help in significantly reducing animal testing.

Q7. In 3D bioprinting market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region due to growing prevalence of chronic diseases, sophisticated healthcare infrastructure along with high disposable income levels in the region, and extensive research activities.

Q8. Do we receive customization in this report?
Answer: Yes, the analyst provides 10% Customization Without any Additional Cost.

This report answers following 11 key questions

Q1. What are some of the most promising, high-growth opportunities for the 3D bioprinting market by technology (magnetic 3D bioprinting, laser-assisted bioprinting, inkjet 3D bioprinting, microextrusion 3D bioprinting, and others), product (3D bioprinters, biomaterials, and scaffolds), material (living cells, extracellular matrices, hydrogels, and others), application (clinical applications, skin, bones, blood vessels, research applications, drug and medical research, regenerative medicine, and 3D cell culture), end use industry (pharmaceutical & biotechnology, research organizations & academic institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q2. Which segments will grow at a faster pace and why?
Q3. Which region will grow at a faster pace and why?
Q4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q5. What are the business risks and competitive threats in this market?
Q6. What are the emerging trends in this market and the reasons behind them?
Q7. What are some of the changing demands of customers in the market?
Q8. What are the new developments in the market? Which companies are leading these developments?
Q9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q11. What M&A activity has occurred in the last five years and what has its impact been on the industry?


This product will be delivered within 1-3 business days.